Drug Companies Told to Do More to Tackle 'Superbug' Crisis

Drugmakers' response to the threat posed by "superbugs" remains patchy even after years of warnings, according to the first analysis of individual companies' efforts to tackle the antibiotic resistance crisis. The rise of drug-resistant bacteria is a growing threat to modern medicine with the emergence of infections resistant to even last-resort antibiotics — a situation made worse in recent years by overuse of antibiotics and cutbacks in drug research. New analysis...

© La Voix de l'Amérique - mardi 23 janvier 2018